Industry Research Reports

Home > Reports > Medical Care > Global Gastrointestinal Cancer Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Gastrointestinal Cancer Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-09-06

Pages: 108 Pages

Report ld: 4990408

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Gastrointestinal Cancer Treatment Market Size(US$)

CAGR 2025-2031

12.6%

Market Size,2031

USD 11,430

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 5,619 million

Market Forecast in 2031(Value)

US$ 11,430 million

CAGR

12.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Gastrointestinal Cancer Treatment market size was US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Gastrointestinal Cancer Treatment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Mylan N.V.
Samsung Bioepis
Teva Pharmaceutical Industries Ltd.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Surgery
Targeted Drugs Therapy
Chemo Therapy
Adjuvant Chemotherapy
Radiation Therapy

Segment by Application

Hospitals
Clinics
Research Centers
Others

biaoTi Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Gastrointestinal Cancer Treatment market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Targeted Drugs Therapy in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Surgery

1.2.3 Targeted Drugs Therapy

1.2.4 Chemo Therapy

1.2.5 Adjuvant Chemotherapy

1.2.6 Radiation Therapy

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Gastrointestinal Cancer Treatment Revenue Market Share by Region (2020-2025)

2.4 Global Gastrointestinal Cancer Treatment Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.2 Europe Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.3 China Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.4 Japan Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.5 Southeast Asia Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.6 India Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

2.5.7 Central & South America Gastrointestinal Cancer Treatment Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2020-2025)

3.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2026-2031)

3.3 Different Types Gastrointestinal Cancer Treatment Representative Players

4 Breakdown Data by Application

4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2020-2025)

4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Gastrointestinal Cancer Treatment Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2020-2025)

5.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue

5.4 Global Gastrointestinal Cancer Treatment Market Concentration Analysis

5.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2024

5.5 Global Key Players of Gastrointestinal Cancer Treatment Head office and Area Served

5.6 Global Key Players of Gastrointestinal Cancer Treatment, Product and Application

5.7 Global Key Players of Gastrointestinal Cancer Treatment, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.1.2.2 North America Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.1.3.2 North America Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.2.2.2 Europe Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.2.3.2 Europe Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.3.2.2 China Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.3.3.2 China Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.4.2.2 Japan Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.4.3.2 Japan Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 Southeast Asia Market: Players, Segments and Downstream

6.5.1 Southeast Asia Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.5.2.2 Southeast Asia Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.5.3.2 Southeast Asia Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.5.4 Southeast Asia Market Trend and Opportunities

6.6 India Market: Players, Segments and Downstream

6.6.1 India Gastrointestinal Cancer Treatment Revenue by Company (2020-2025)

6.6.2 India Market Size by Type

6.6.2.1 India Gastrointestinal Cancer Treatment Market Size by Type (2020-2025)

6.6.2.2 India Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

6.6.3 India Market Size by Application

6.6.3.1 India Gastrointestinal Cancer Treatment Market Size by Application (2020-2025)

6.6.3.2 India Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Eli Lilly

7.1.1 Eli Lilly Company Details

7.1.2 Eli Lilly Business Overview

7.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction

7.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.1.5 Eli Lilly Recent Development

7.2 F. Hoffmann

7.2.1 F. Hoffmann Company Details

7.2.2 F. Hoffmann Business Overview

7.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction

7.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.2.5 F. Hoffmann Recent Development

7.3 GlaxoSmithKline

7.3.1 GlaxoSmithKline Company Details

7.3.2 GlaxoSmithKline Business Overview

7.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction

7.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.3.5 GlaxoSmithKline Recent Development

7.4 Merck

7.4.1 Merck Company Details

7.4.2 Merck Business Overview

7.4.3 Merck Gastrointestinal Cancer Treatment Introduction

7.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.4.5 Merck Recent Development

7.5 Novartis AG

7.5.1 Novartis AG Company Details

7.5.2 Novartis AG Business Overview

7.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction

7.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.5.5 Novartis AG Recent Development

7.6 Otsuka Holdings

7.6.1 Otsuka Holdings Company Details

7.6.2 Otsuka Holdings Business Overview

7.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction

7.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.6.5 Otsuka Holdings Recent Development

7.7 Stryker Corporation

7.7.1 Stryker Corporation Company Details

7.7.2 Stryker Corporation Business Overview

7.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction

7.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.7.5 Stryker Corporation Recent Development

7.8 Boston Scientific Corporation

7.8.1 Boston Scientific Corporation Company Details

7.8.2 Boston Scientific Corporation Business Overview

7.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction

7.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.8.5 Boston Scientific Corporation Recent Development

7.9 Johnson and Johnson

7.9.1 Johnson and Johnson Company Details

7.9.2 Johnson and Johnson Business Overview

7.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction

7.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.9.5 Johnson and Johnson Recent Development

7.10 CONMED Corporation

7.10.1 CONMED Corporation Company Details

7.10.2 CONMED Corporation Business Overview

7.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction

7.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.10.5 CONMED Corporation Recent Development

7.11 Bristol-Myers Squibb

7.11.1 Bristol-Myers Squibb Company Details

7.11.2 Bristol-Myers Squibb Business Overview

7.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction

7.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.11.5 Bristol-Myers Squibb Recent Development

7.12 Pfizer

7.12.1 Pfizer Company Details

7.12.2 Pfizer Business Overview

7.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction

7.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.12.5 Pfizer Recent Development

7.13 Celltrion Inc

7.13.1 Celltrion Inc Company Details

7.13.2 Celltrion Inc Business Overview

7.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction

7.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.13.5 Celltrion Inc Recent Development

7.14 Amgen Limited

7.14.1 Amgen Limited Company Details

7.14.2 Amgen Limited Business Overview

7.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction

7.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.14.5 Amgen Limited Recent Development

7.15 Celgene Corporation

7.15.1 Celgene Corporation Company Details

7.15.2 Celgene Corporation Business Overview

7.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction

7.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.15.5 Celgene Corporation Recent Development

7.16 Sanofi

7.16.1 Sanofi Company Details

7.16.2 Sanofi Business Overview

7.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction

7.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.16.5 Sanofi Recent Development

7.17 Mylan N.V.

7.17.1 Mylan N.V. Company Details

7.17.2 Mylan N.V. Business Overview

7.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Introduction

7.17.4 Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.17.5 Mylan N.V. Recent Development

7.18 Samsung Bioepis

7.18.1 Samsung Bioepis Company Details

7.18.2 Samsung Bioepis Business Overview

7.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Introduction

7.18.4 Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.18.5 Samsung Bioepis Recent Development

7.19 Teva Pharmaceutical Industries Ltd.

7.19.1 Teva Pharmaceutical Industries Ltd. Company Details

7.19.2 Teva Pharmaceutical Industries Ltd. Business Overview

7.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Introduction

7.19.4 Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2020-2025)

7.19.5 Teva Pharmaceutical Industries Ltd. Recent Development

8 Gastrointestinal Cancer Treatment Market Dynamics

8.1 Gastrointestinal Cancer Treatment Industry Trends

8.2 Gastrointestinal Cancer Treatment Market Drivers

8.3 Gastrointestinal Cancer Treatment Market Challenges

8.4 Gastrointestinal Cancer Treatment Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Gastrointestinal Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Gastrointestinal Cancer Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Gastrointestinal Cancer Treatment Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Gastrointestinal Cancer Treatment Revenue Share by Region (2020-2025)

Table 6. Global Gastrointestinal Cancer Treatment Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Gastrointestinal Cancer Treatment Revenue Share Forecast by Region (2026-2031)

Table 8. Global Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 10. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 15. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Gastrointestinal Cancer Treatment Application

Table 18. Global Gastrointestinal Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Gastrointestinal Cancer Treatment Market Share by Players (2020-2025)

Table 20. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2024)

Table 21. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Gastrointestinal Cancer Treatment, Headquarters and Area Served

Table 24. Global Key Players of Gastrointestinal Cancer Treatment, Product and Application

Table 25. Global Key Players of Gastrointestinal Cancer Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 29. North America Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 33. Europe Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 37. China Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 41. Japan Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Gastrointestinal Cancer Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Gastrointestinal Cancer Treatment Revenue Market Share by Company (2020-2025)

Table 49. India Gastrointestinal Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Gastrointestinal Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 51. Eli Lilly Company Details

Table 52. Eli Lilly Business Overview

Table 53. Eli Lilly Gastrointestinal Cancer Treatment Product

Table 54. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 55. Eli Lilly Recent Development

Table 56. F. Hoffmann Company Details

Table 57. F. Hoffmann Business Overview

Table 58. F. Hoffmann Gastrointestinal Cancer Treatment Product

Table 59. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 60. F. Hoffmann Recent Development

Table 61. GlaxoSmithKline Company Details

Table 62. GlaxoSmithKline Business Overview

Table 63. GlaxoSmithKline Gastrointestinal Cancer Treatment Product

Table 64. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 65. GlaxoSmithKline Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Gastrointestinal Cancer Treatment Product

Table 69. Merck Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Novartis AG Company Details

Table 72. Novartis AG Business Overview

Table 73. Novartis AG Gastrointestinal Cancer Treatment Product

Table 74. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 75. Novartis AG Recent Development

Table 76. Otsuka Holdings Company Details

Table 77. Otsuka Holdings Business Overview

Table 78. Otsuka Holdings Gastrointestinal Cancer Treatment Product

Table 79. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 80. Otsuka Holdings Recent Development

Table 81. Stryker Corporation Company Details

Table 82. Stryker Corporation Business Overview

Table 83. Stryker Corporation Gastrointestinal Cancer Treatment Product

Table 84. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 85. Stryker Corporation Recent Development

Table 86. Boston Scientific Corporation Company Details

Table 87. Boston Scientific Corporation Business Overview

Table 88. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product

Table 89. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 90. Boston Scientific Corporation Recent Development

Table 91. Johnson and Johnson Company Details

Table 92. Johnson and Johnson Business Overview

Table 93. Johnson and Johnson Gastrointestinal Cancer Treatment Product

Table 94. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 95. Johnson and Johnson Recent Development

Table 96. CONMED Corporation Company Details

Table 97. CONMED Corporation Business Overview

Table 98. CONMED Corporation Gastrointestinal Cancer Treatment Product

Table 99. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 100. CONMED Corporation Recent Development

Table 101. Bristol-Myers Squibb Company Details

Table 102. Bristol-Myers Squibb Business Overview

Table 103. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product

Table 104. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 105. Bristol-Myers Squibb Recent Development

Table 106. Pfizer Company Details

Table 107. Pfizer Business Overview

Table 108. Pfizer Gastrointestinal Cancer Treatment Product

Table 109. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 110. Pfizer Recent Development

Table 111. Celltrion Inc Company Details

Table 112. Celltrion Inc Business Overview

Table 113. Celltrion Inc Gastrointestinal Cancer Treatment Product

Table 114. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 115. Celltrion Inc Recent Development

Table 116. Amgen Limited Company Details

Table 117. Amgen Limited Business Overview

Table 118. Amgen Limited Gastrointestinal Cancer Treatment Product

Table 119. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 120. Amgen Limited Recent Development

Table 121. Celgene Corporation Company Details

Table 122. Celgene Corporation Business Overview

Table 123. Celgene Corporation Gastrointestinal Cancer Treatment Product

Table 124. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 125. Celgene Corporation Recent Development

Table 126. Sanofi Company Details

Table 127. Sanofi Business Overview

Table 128. Sanofi Gastrointestinal Cancer Treatment Product

Table 129. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 130. Sanofi Recent Development

Table 131. Mylan N.V. Company Details

Table 132. Mylan N.V. Business Overview

Table 133. Mylan N.V. Gastrointestinal Cancer Treatment Product

Table 134. Mylan N.V. Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 135. Mylan N.V. Recent Development

Table 136. Samsung Bioepis Company Details

Table 137. Samsung Bioepis Business Overview

Table 138. Samsung Bioepis Gastrointestinal Cancer Treatment Product

Table 139. Samsung Bioepis Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 140. Samsung Bioepis Recent Development

Table 141. Teva Pharmaceutical Industries Ltd. Company Details

Table 142. Teva Pharmaceutical Industries Ltd. Business Overview

Table 143. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Product

Table 144. Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Cancer Treatment Business (2020-2025) & (US$ Million)

Table 145. Teva Pharmaceutical Industries Ltd. Recent Development

Table 146. Gastrointestinal Cancer Treatment Market Trends

Table 147. Gastrointestinal Cancer Treatment Market Drivers

Table 148. Gastrointestinal Cancer Treatment Market Challenges

Table 149. Gastrointestinal Cancer Treatment Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastrointestinal Cancer Treatment Product Picture

Figure 2. Global Gastrointestinal Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 3. Surgery Features

Figure 4. Targeted Drugs Therapy Features

Figure 5. Chemo Therapy Features

Figure 6. Adjuvant Chemotherapy Features

Figure 7. Radiation Therapy Features

Figure 8. Global Gastrointestinal Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Research Centers

Figure 12. Others

Figure 13. Gastrointestinal Cancer Treatment Report Years Considered

Figure 14. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Gastrointestinal Cancer Treatment Revenue Market Share by Region: 2020 VS 2024

Figure 17. North America Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Europe Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. China Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Japan Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Southeast Asia Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. India Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Central & South America Gastrointestinal Cancer Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Global Gastrointestinal Cancer Treatment Market Share by Players in 2024

Figure 25. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2024)

Figure 26. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2024

Figure 27. North America Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 28. North America Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 29. Europe Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 30. Europe Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 31. China Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 32. China Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 33. Japan Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 34. Japan Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 35. Southeast Asia Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 36. Southeast Asia Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 37. India Gastrointestinal Cancer Treatment Market Share by Type (2020-2025)

Figure 38. India Gastrointestinal Cancer Treatment Market Share by Application (2020-2025)

Figure 39. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 40. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 41. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 42. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 43. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 44. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 45. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 46. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 47. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 48. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 51. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 52. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 53. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 55. Mylan N.V. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 56. Samsung Bioepis Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 57. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

Related Reports

Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-01-24
Pages: 133
USD 3950.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2024
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-01-31
Pages: 94
USD 2900.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published Date: 2024-04-26
Pages: 118
USD 4900.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2025
The global market for Gastrointestinal Cancer Treatment was valued at US$ 5049 million in the year 2024 and is projected to reach a revised size of US$ 11430 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published Date: 2025-02-27
Pages: 91
USD 2900.00
(Single User License)
Gastrointestinal Cancer Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 122
USD 3950.00
(Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2026
The global Gastrointestinal Cancer Treatment market was valued at US$ 5619 million in 2025 and is anticipated to reach US$ 12720 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 124
USD 2900.00
(Single User License)
Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5619 million in 2025 and is projected to reach US$ 12720 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 137
USD 3950.00
(Single User License)

Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-01-24
Pages: 133
USD 3950.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2024
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-01-31
Pages: 94
USD 2900.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Insights, Forecast to 2030
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.
Published: 2024-04-26
Pages: 118
USD 4900.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2025
The global market for Gastrointestinal Cancer Treatment was valued at US$ 5049 million in the year 2024 and is projected to reach a revised size of US$ 11430 million by 2031, growing at a CAGR of 12.6% during the forecast period.
Published: 2025-02-27
Pages: 91
USD 2900.00 (Single User License)
Gastrointestinal Cancer Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5049 million in 2024 and is forecast to a readjusted size of US$ 11430 million by 2031 with a CAGR of 12.6% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 122
USD 3950.00 (Single User License)
Global Gastrointestinal Cancer Treatment Market Research Report 2026
The global Gastrointestinal Cancer Treatment market was valued at US$ 5619 million in 2025 and is anticipated to reach US$ 12720 million by 2032, at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-04-27
Pages: 124
USD 2900.00 (Single User License)
Gastrointestinal Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gastrointestinal Cancer Treatment was estimated to be worth US$ 5619 million in 2025 and is projected to reach US$ 12720 million, growing at a CAGR of 12.6% from 2026 to 2032.
Published: 2026-07-14
Pages: 137
USD 3950.00 (Single User License)